Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00403546
Status:
COMPLETED
Last Update Posted:
2017-06-06
First Post:
2006-11-21
Brief Title:
High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia Symptoms
Sponsor:
Donald C Goff MD
Organization:
Massachusetts General Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01
Start Date Type:
ACTUAL
Primary Completion Date:
2011-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-21
First Submit QC Date:
November 22 2006
Study First Post Date:
2006-11-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-06-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-02
Last Update Post Date:
2017-06-06
Last Update Post Date Type:
ACTUAL